Financings Of The Fortnight: Crossover Investors Key To Intarcia’s Massive $210 Million Series C Round
This article was originally published in The Pink Sheet Daily
Executive Summary
Plus news on recent financings by Visterra, AbbVie, Pearl Therapeutics and Auspex.